This white paper from NSF consultant Richard Kettlewell builds on an earlier white paper from Pete Gough, which introduces the regulatory expectations for Stage 3 of the process verification lifecycle. This article poses questions to pharmaceutical manufacturers as to how and why the concepts of Stage 3 could be built into pharmaceutical quality systems.